RankingsPricing
  1. JP-listed companies
  2. OncoTherapy Science, Inc.

OncoTherapy Science, Inc.JP:4564

Market cap
¥9.6B
P/E ratio
Back to summarized table
Income statementBalance sheetCash flow
Mar 31,
2013		Mar 31,
2014		Mar 31,
2015		Mar 31,
2016		Mar 31,
2017		Mar 31,
2018		Mar 31,
2019		Mar 31,
2020		Mar 31,
2021		Mar 31,
2022		Mar 31,
2023		Mar 31,
2024
Business revenue3,2771,0187702672872112813163321,1541,135610
Research and development expenses---2,8842,9382,9322,8271,7421,3761,730716678
Cost of sales-------3663131,0401,093788
Selling, general and administrative expenses268332339364353268408397282436432265
Research and development expenses---2,8842,9382,9322,8271,7421,3761,730716678
Total business expenses4,3914,8042,7323,2483,2913,2003,2342,5061,9703,2062,2411,731
Selling, general and administrative expenses268332339364353268408397282436432265
Total business expenses4,3914,8042,7323,2483,2913,2003,2342,5061,9703,2062,2411,731
Operating profit (loss)-1,114-3,786-1,962-2,981-3,004-2,989-2,954-2,190-1,638-2,053-1,106-1,121
Interest on tax refund-158000001000
Interest income-3972110001211
Other-------0-000
Outsourcing service income----------1520
Non-operating income5203518211122110
Interest on tax refund-158000001000
Other-------0-000
Non-operating income5203518211122110
Interest expenses-----------0
Relocation expenses----------16-
Relocation expenses----------16-
Share issuance costs-------10-6310
Share issuance costs-------10-6310
Foreign exchange losses5-12-6-6-41496
Foreign exchange losses5-12-6-6-41496
Non-operating expenses5213-606104202716
Non-operating expenses5213-606104202716
Ordinary profit (loss)-1,114-3,768-1,940-2,963-3,009-2,977-2,959-2,197-1,639-2,072-1,133-1,136
Gain on sale of non-current assets-------50000-
Gain on reversal of share acquisition rights452317174115883879049385
Extraordinary income4525781741158831389049385
Gain on extinguishment of tie-in shares-----------264
Extraordinary income4525781741158831389049385
Impairment losses------3191661154822155
Extraordinary losses20-----3191771154822155
Provision of allowance for doubtful accounts----------48370
Provision for loss on business of subsidiaries and associates-----------33
Extraordinary losses20-----3191771154822155
Profit (loss) before income taxes-1,129-3,716-1,362-2,789-2,998-2,919-3,195-2,237-1,560-2,570-1,116-1,286
Income taxes - current5420555533332
Income taxes - deferred-5-4-5-3-02-8-1-1-2-0-
Income taxes-1-95-44-147-322122
Profit (loss)---1,318-2,789-3,002-2,926-3,192-2,239-1,562-2,572-1,119-1,288
Profit (loss) attributable to owners of parent---1,335-2,789-3,002-2,851-2,935-2,239-1,562-2,572-1,119-1,288